Ms. LI Ru, aged 42, was appointed to the Board on 18 February 2019. Ms. LI graduated from pharmaceutical preparations at Shenyang Pharmaceutical University in 2001. She was product manager, regional sales manager and divisional sales manager of the narcotics department at China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (a company listed on the Shanghai Stock Exchange, stock code: 600511) successively from September 2001 to January 2010, and market manager of Nycomed Pharma AS (奈科明制药有限公司) from January 2010 to January 2012. From January 2012 until the present, she has acted as deputy director and director of the risk and operation management department and director of the legal and risk management department of CNPGC successively. Ms. LI is currently the director of the legal and risk management department of CNPGC.
Mr. YANG Binghua, aged 41, was appointed to the Board on 24 December 2018. Mr. YANG obtained a bachelor degree in Politics and Administration of Public Administration from China Youth University for Political Sciences in 2004 and obtained a master degree in Public Administration from School of Government of Peking University in 2011. He was previously a staff member, a senior staff member and a principal staff member of the information research office of the State Council State-owned Assets Supervision and Administration Commission ("SASAC") Office from July 2004 to December 2013; person-incharge of the basic training programme of Daqing Oilfield production plant No.2 from April 2010 to March 2011; person-in-charge of the basic training programme of the governmental and enterprises customers division of China Telecom from August 2012 to December 2013; the deputy department head of the second secretarial department, a deputy director of the department party committee office, the deputy department head of the promotional department of the department party committee and the department head of the promotional department of the department party committee of the State Council SASAC Office from December 2013 to March 2017. In which, he served as a staff member of the management enhancement group office of asset committee authorities from July 2012 to August 2014. He was previously a deputy director of department of party-masses relationship and a deputy director of department of party-people relationship (incharge of the department) of CNPGC from March 2017 to May 2018. He is currently a principal staff of department of party-masses relationship of CNPGC. Mr. YANG has served as a non-independent director of Chongqing Taiji Industry (Group) Co., Ltd. (a company listed on the Shanghai Stock Exchange, stock code: 600129) since 19 May 2021.
Mr. WANG Kan, aged 37, was appointed to the Board on 24 December 2018. Mr. WANG obtained a bachelor degree in Pharmacy from the School of Pharmacy of Peking University Health Science Center in 2007, a master degree in Pharmacy from the School of Pharmacy of Peking University Health Science Center and double bachelor degree of Economics from China Center for Economic Research of Peking University in 2009. Mr. WANG was a staff member of planning development and industrial management department of China National Pharmaceutical Industry Company Limited from August 2009 to May 2010; a staff member of the investment management department and securities department of China National Biotech Group Company Limited from May 2010 to November 2014; and a senior business executive and assistant of manager of the investment management department of CNPGC from November 2014 to January 2018. He has also been a director of Suzhou Capsugel Co., Ltd. in March 2018. Mr. WANG has served as a non-independent director of Chongqing Taiji Industry (Group) Co., Ltd. (a company listed on the Shanghai Stock Exchange, stock code: 600129) since 19 May 2021. He is currently the deputy manager of the investment management department of CNPGC.
Mr. MENG Qingxin, aged 42. Mr. MENG was graduated from Northwest Minzu University in environmental engineering in 2003. Mr. MENG has a senior engineering qualification. From August 2003 to August 2007, Mr. MENG served as the technical safety specialist in equipment department of the 200 National Factory; from August 2007 to February 2009, he served as a technical safety specialist in equipment department of Beijing Aerospace Guanghua Electronics Technology Co., Ltd.; from February 2009 to December 2012, he served as a deputy director of equipment department and a deputy director of safety and security department of Beijing Aerospace Guanghua Electronics Technology Co., Ltd.; from December 2012 to October 2013, he served as a deputy director of the Ninth Standardization Research Office of China Aerospace Science and Technology Corporation. Since October 2013, he has successively served as a senior supervisor, a director assistant and a deputy director of the safety, environmental protection and quality management department of China National Pharmaceutical Group Corporation (currently known as China National Pharmaceutical Group Co., Ltd.).